caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1659442507

Gary WeissMD, PHD

UrologyNew Hyde Park, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Gary Weiss's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
2931,355
NORTH SHORE UNIVERSITY HOSPITAL1821,114
LONG ISLAND JEWISH MEDICAL CENTER56312
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Melville, NY
40182
Eran Ben-Levi
Diagnostic Radiology · Manhasset, NY
2560
Sunrise Medical Laboratories, Inc.
Clinical Laboratory · Hicksville, NY
1362
Oksana Yaskiv
Pathology · Saint Louis, MO
1238
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1130
Gregory Grimaldi
Diagnostic Radiology · New York, NY
1136
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
581
Unique beneficiaries
—
Total services
1,044
Distinct HCPCS
8
Medicare payment
$122K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 756 Urology providers in NY — above median (cohort median 1,574).
PRESCRIBING · PART D · 2024
Total Rx claims
2,316
Beneficiaries
—
Total drug cost
$325K
Distinct drugs
38
Brand share
21.1%
Top prescribed drugs
Tamsulosin Hcl567 claims
Finasteride205 claims
Silodosin179 claims
Vibegron128 claims
Desipramine Hcl91 claims
QUALITY · MIPS · 2024
Final MIPS score
93.1
Quality
79.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
88.8
Payment adjustment
0.76%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.